CoChat

Mechanism of depression as a risk factor in the development of Alzheimer’s disease: the function of AQP4 and the glymphatic system

Xia, Maosheng, Yang, Li, Sun, Guangfeng, Qi, Shuang, Li, Baoman · 2017 · Psychopharmacology

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Abstract

Background Many studies have indicated that a history of depression increases the risk of developing Alzheimer's disease (AD); however, the potential pathogenestic mechanism by which depression functions as a high risk factor for AD remains unknown. Recently, a "cerebral lymphatic system" referred to as "glymphatic system" has been demonstrated to be responsible for neuronal extracellular waste protein clearance via a paravascular pathway. However, the function of glymphatic pathway has not been determined in depressive disorders. Methods The present study used an animal model of chronic unpredictable mild stress (CUMS) to determine the function of glymphatic pathway by using fluorescence tracers. Immunohistochemistry was used to assess the accumulation of endogenous mouse and exogenous human amyloid beta 42 (Aβ42) in CUMS-treated mice with or without treatment with antidepressant fluoxetine. Findings Glymphatic pathway circulation was impaired in mice treated with CUMS; moreover, glymphatic pathway dysfunction suppressed Aβ42 metabolism, because the accumulation of endogenous and exogenous Aβ42 was increased in the brains of the CUMS-treated mice. However, treatment with fluoxetine reversed these destructive effects of CUMS on glymphatic system. In anhedonic mice, the expression of the water channel aquaporin 4 (AQP4), a factor in glymphatic pathway dysfunction, was down-regulated in cortex and hippocampus. Conclusion The dysfunction of glymphatic system suggested why a hist…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00213-016-4473-9

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 59 references

Research works printed but not linked: 1

  1. Jorm AF (2011) History of depression as a risk factor for dementia: an updated review. Aust NZ J Psychiatry 35:776–781 · DOI · Paper page

Cited by

See all 149

Metadata

Authors
Xia, M., Yang, L., Sun, G., Qi, S., & Li, B.
Affiliations
  • First Hospital of China Medical University (CN)
  • China Medical University (CN)
Corresponding author
Li, Baoman
Venue
Psychopharmacology
Published
2016-11-12
Volume
234
Issue
3
Pages
365-379
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2550905642
Cited by
149
References
59
Citations by year
2026: 16 · 2025: 14 · 2024: 21 · 2023: 25 · 2022: 23 · 2021: 15 · 2020: 17 · 2019: 9 · 2018: 5 · 2017: 4
FWCI
3.38
Type
journal article
Language
en
Open access
closed
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81200935)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
Keywords
depression, Alzheimer's disease, glymphatic system, aquaporin-4, amyloid-beta 42, chronic unpredictable mild stress, fluoxetine, anhedonia, antidepressant treatment, hippocampus, cortex
MeSH terms
Alzheimer Disease, Animals, Antidepressive Agents, Brain, Depressive Disorder, Disease Models, Animal, Fluoxetine, Hippocampus, Humans, Immunohistochemistry, Lymphatic System, Male, Peptide Fragments, Risk Factors, Stress, Psychological, Amyloid beta-Peptides, Mice, Aquaporin 4, Anhedonia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanism of depression as a risk factor in the development of Alzheimer’s disease: the function of AQP4 and the glymphatic system. https://app.cochat.ai/papers/10.1007/s00213-016-4473-9
The paper
Xia, M., Yang, L., Sun, G., Qi, S., & Li, B. (2017). Mechanism of depression as a risk factor in the development of Alzheimer’s disease: the function of AQP4 and the glymphatic system. Psychopharmacology. https://doi.org/10.1007/s00213-016-4473-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.